TCL Archive Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations June 28, 2013
TCL Archive In Brief: Chabner Names DCT Acting Director, Schepartz Returns To Deputy Job; GM Winners Announced July 3, 1981
TCL Archive WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use November 2, 2002
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
